Metacare Co., Ltd. stock analysis
Want to see KR:118000 full AI Analyst Report?
Metacare Co., Ltd. (118000) Stock Price & Analysis
118000 Stock Chart & Stats
- Day’s Range
- KRW 822.00 - KRW 904.00
- 52-Week Range
- KRW 720.00 - KRW 3,780.00
- Previous Close
- KRW 880.00
- Volume
- N/A
- Average Volume (3M)
- 98.86K
- Market Cap
- KRW 19.41B
- Enterprise Value
- KRW 96.59B
- Total Cash (Recent Filing)
- KRW 11.07B
- Total Debt (Recent Filing)
- KRW 73.97B
- Price to Earnings (P/E)
- ―
- Beta
- 0.19
- Next Earnings
- Mar 24, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue Growth And Operating Profitability
The combination of rising TTM revenue and positive operating profitability indicates that the business is expanding while still generating operating earnings. This provides a foundation for reinvestment and suggests the company retains viable operating leverage despite weaker bottom-line results.
Positive Operating And Free Cash Flow
A return to positive operating and free cash flow improves the company’s ability to fund operations internally and reduces reliance on external financing. Although consistency remains unproven, recent cash generation gives management greater flexibility to support ongoing business needs.
Solid Equity Base
The substantial equity base provides a meaningful balance-sheet cushion relative to total assets. This supports financial resilience and can help the company absorb operating volatility, preserve access to funding, and maintain strategic flexibility while profitability recovers.
Bears Say
Net Loss And Margin Compression
Recent losses and materially weaker margins indicate that revenue growth is not yet translating consistently into shareholder earnings. Continued margin pressure could limit reinvestment capacity, weaken returns, and make future profitability more dependent on improving cost discipline.
Rising Leverage
The steady increase in debt relative to equity reduces financial flexibility at a time when profitability and returns are under pressure. Higher leverage can increase financing demands and leave fewer options to absorb further earnings volatility or fund growth internally.
Inconsistent Cash-Flow Durability
Positive recent cash flow is encouraging, but the decline in TTM free cash flow and history of negative operating cash flow show that cash generation has not yet become dependable. This uncertainty can constrain planning and weaken confidence in internally funded growth.
Metacare Co., Ltd. News
118000 FAQ
What was Metacare Co., Ltd.’s price range in the past 12 months?
What is Metacare Co., Ltd.’s market cap?
When is Metacare Co., Ltd.’s upcoming earnings report date?
How were Metacare Co., Ltd.’s earnings last quarter?
Is Metacare Co., Ltd. overvalued?
Does Metacare Co., Ltd. pay dividends?
What is Metacare Co., Ltd.’s EPS estimate?
How many shares outstanding does Metacare Co., Ltd. have?
What happened to Metacare Co., Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Metacare Co., Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Metacare Co., Ltd.
Headquartered in Seoul, South Korea, Wooridul Huebrain Limited was founded in 2009. The company's operations span the medical, life and health, pharmaceutical, and storage industries. Its offerings include a range of medical equipment and devices, health-related apparatus, pharmaceutical products, and computer server solutions. The firm rebranded as Wooridul Huebrain Limited in April 2014, having previously operated under the name Wooridul Life Sciences Limited.
- Sector
- General
- Industry
- Drug Manufacturers - General
- CEO
- Soo-Kyung Kim
- Employees
- 32
- Website
- www.meta-care.co.kr
- Address
- No. 202, 156 Byeongjeomjungang-ro, Hwaseong-si, GY, 06232, KR
Metacare Co., Ltd. (118000) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 5 | 12 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 2 | 0 | 10 |


